BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Polyphor 

Hegenheimermattweg 125

Allschwil    CH-4123  Switzerland
Phone: 41-61-567-1600 Fax: 41-61-567-1601


SEARCH JOBS




Industry
Biotechnology

Segment
Drug Discovery





 Company News
Roche (RHHBY) to Pay Polyphor Up to $548 Million for Superbug Antibiotic 11/4/2013 7:13:44 AM
Polyphor Achieves First Milestone in Macrocycle Drug Discovery Collaboration With Boehringer Ingelheim Corporation 7/31/2013 9:15:00 AM
Polyphor Attracts Senior Pharma Professionals to Strengthen Its Board of Directors 6/11/2013 8:51:41 AM
Polyphor Reports Successful Phase I Results for Its Pseudomonas Selective Antibiotic POL7080 3/4/2013 11:46:40 AM
Polyphor Signs MacroFinder® Collaboration With Boehringer Ingelheim Corporation 6/12/2012 7:47:36 AM
Axxam srl and Polyphor Participate in a Research Partnership for the Treatment of Type-2 Diabetes Funded by the EU 7/27/2011 9:32:12 AM
Polyphor Announces First PEMfinder(R) collaboration with Big Pharma, Novartis Pharmaceuticals Corporation (NVS) 5/6/2010 10:52:14 AM
Polyphor And University of Zurich Discovers A New Class Of Antibiotics With A Novel Mode Of Action 2/23/2010 11:21:17 AM
Polyphor Discovers a New Class of Antibiotics with a Novel Mode of Action 2/19/2010 9:56:16 AM
Polyphor to Enter into an Exclusive Agreement with Allergan Inc. (AGN) for the Development of Protein Epitope Mimetics (PEM) Inhibitors for Ophthalmology; Allergan Entitled to Receive up to $61.0 Million 10/31/2008 6:27:13 AM
12